Skip to content

Electrical Muscle Stimulation: A New Approach to Managing PCOS Health Challenges

Impact of Electrical Muscle Stimulation on Metabolic, Somatic, and Psychosocial Health in Polycystic Ovary Syndrome Patients: A Randomized Control Trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/094401
Enrollment
42
Registered
2025-09-08
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E00-E89- Endocrine, nutritional and metabolic diseases

Interventions

Intervention1: EMS INTERVENTIONAL GROUP: Multi-channel 8 channels electrical stimulator will be used to deliver Russian current of 2500 Hz of motor level intensity with 10 seconds of stimulation follo

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Medically diagnosed and according to Rotterdam criteria (at least two of the following oligo/anovulation, clinical and/or biochemical signs of hyperandrogenism, polycystic ovaries)BMI more than 24 kg/m? (Sam S. Obesity and Polycystic Ovary Syndrome. Obes Manag. 2007 Apr;3(2):69-73. doi: 10.1089/obe.2007.0019. PMID: 20436797; PMCID:PMC2861983) Willing to provide informed consent and comply with study protocol.

Exclusion criteria

Exclusion criteria: Use of hormonal medications like oral contraceptives within the last 3 months Pregnant or planning to become pregnant within the study period Any neurological disorders like multiple sclerosis amyotrophic lateral sclerosis Guillain Barre syndrome etc Any systemic disease like liver dysfunction IBD Kidney failure etc Any congenital disorders like Turner Syndrome Congenital Adrenal Hyperplasia Marfan syndrome History of Cancer Diagnosed with other endocrine disorders like thyroid dysfunction Cushing syndrome etc History of any cardiovascular diseases like uncontrolled hypertension unstable angina etc Participation in another clinical trial at present and within the last six months

Design outcomes

Primary

MeasureTime frame
Insulin Resistance Menstrual health Glucose metabolism Plasma Glucose level Hyperandrogenism quality of lifeTimepoint: base line 12 weeks and follow up 3 months

Secondary

MeasureTime frame
BMI , Body composition analysis , hip to waist ratioTimepoint: base line 12 weeks and follow up 3 months

Countries

India

Contacts

Public ContactDivya Goyal

Department of physiotherapy , School of healthcare and allied sciences ,GD Goenka University

tabish.fahim@gdgu.org9718481337

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026